Browse All

Current Filters

CLEAR FILTER x

TITLE

Thrombectomy for the Treatment of Large Core Ischemic Strokes: An Updated Systematic Review and Meta-analysis After the Release of the TESLA and TENSION Trials

Author:Dibas, Mahmoud   Almajali, Mohammad   Ghannam, Malik   Galecio-Castillo, Milagros   Qudah, Abdullah Al   Khasiyev, Farid   Vivanco-Suarez, Juan   Calienes, Aaron Rodriguez   Shogren, Sophie   Al Majali, Fawaz   Yoo, Albert   Samaniego, Edgar   Sarraj, Amrou   Ortega Gutierrez, Santiago   

Session Name:P9: Cerebrovascular Disease and Interventional Neurology: Stroke Treatment Outcomes and Rehabilitation Strategies  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P9.001  

Author Institution:Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA, Qassim, Saudi Arabia  University of Iowa Hospital and Clinics, Iowa City, IA  Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA, Coralville, IA  Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA, Iowa City, IA  Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA, Pittsburgh, PA  Department of Neurology, Saint Louis University, Saint Louis, MO, USA, Saint Louis, MO  Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, US, Iowa City, IA  University of Iowa Hospitals and Clinics, Iowa City, IA  Department of General Surgery, Saint Louis University, Saint Louis, MO, US, Saint Louis, MO  Texas Stroke Institute, Dallas, TX  Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, OH, US, Shaker Heights, OH  University of Iowa, Iowa City, IA  

Real-world Digital Biomarkers Index Circadian Rest-activity Rhythms in Persons Taking Dopaminergic Medications for Parkinson’s Disease

Biological Staging of the Parkinson’s Progression Markers Initiative (PPMI) Cohort Using the Research Neuronal a-synuclein Disease Integrated Staging System (NSD-ISS)

Author:Tanner, Caroline   Simuni, Tanya   Chahine, Lana   Poston, Kathleen   Brumm, Michael   Chowdry, Sohini   Coffey, Christopher   Concha-Marambio, Luis   Dam, Tien   DiBiaso, Peter   Foroud, Tatiana   Frasier, Mark   Gochanour, Caroline   Jennings, Danna   Kieburtz, Karl   Kopil, Catherine   Merchant, Kalpana   Mollenhauer, Brit   Montine, Thomas   Nudelman, Kelly   Pagano, Gennaro   Seibyl, John   Sherer, Todd   Singleton, Andrew   Stephenson, Diane   Stern, Matthew   Soto, Claudio   Tolosa, Eduardo   Weintraub, Daniel   Xiao, Yuge   Siderowf, Andrew   Poewe, Werner   Marek, Kenneth   

Session Name:P11: Movement Disorders: Parkinson's Disease Epidemiology, Genetics, and Biomarkers 2  

Topic:Movement Disorders  

Program Number:P11.009  

Author Institution:University of California San Francisco, Weill Institute for Neurosciences, San Francisco, CA  Northwestern University Feinberg School of Medicien, Chicago, IL  University of Pittsburgh, Pittsburgh, PA  Stanford University, Stanford, CA  University of Iowa, Iowa City, IA  The Michael J. Fox Foundation for Parkinson's Research, New York, NY  Amprion, San Francisco, CA  Neumora Therapeutics Inc, Watertown, MA  Indiana University School of Medicine, Indianapolis, IN  Denali Therapeutics, South San Francisco, CA  University of Rochester Medical Center, Rochester, NY  Northwestern University, Chicago, IL  University of Goettingen, Goettingen, Germany  Indiana University , Indianapolis, IN  F. Hoffmann-La Roche Ltd, Basel, Switzerland  Institute for Neurodegenerative Disorders, Branford, CT  National Institute of Aging, Bethesda, MD  Critical Path Institute, Tucson, AZ  University of Pennsylvania, Philadelphia, PA  University of Texas McGovern Medical School , Houston, TX  Unviersity of Barcelona, Barcelona, Spain  University of Pennsylvania, Narberth, PA  University Hospital of Neurology, Innsbruck, Austria  Institute for Neurodegenerative Disorders, New Haven, CT